| Description | Dot1l Mouse Pre-designed siRNA Set A contains three designed siRNAs for Dot1l gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control. Components Dot1l siRNA-1: 5 nmol (HPLC) Dot1l siRNA-2: 5 nmol (HPLC) Dot1l siRNA-3: 5 nmol (HPLC) siRNA Negative Control:Dot1l Mouse Pre-designed siRNA Set A contains three designed siRNAs for Dot1l gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control. Components Dot1l siRNA-1: 5 nmol (HPLC) Dot1l siRNA-2: 5 nmol (HPLC) Dot1l siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA produces a relapsing-remitting neurological disease with extensive plaque-like demyelination... Read More | Inquire | Purity>95% (SDS-PAGE) Endotoxin level<1.0 EU/µgFunctionInhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T-cells |